| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.26 | 2e-08 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.29 | 3e-07 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.29 | 7e-07 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.18 | 7e-05 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.17 | 0.0005 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.006 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.14 | 0.007 |